Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort

Introduction Sex differences in cardiometabolic risk factors and their management in type 2 diabetes (T2D) have not been fully identified. Therefore, we aimed to examine differences in cardiometabolic risk factor levels, pharmacological treatment and achievement of risk factor control between women and men with T2D.Research design and methods Cross-sectional data from the Dutch Diabetes Pearl cohort were used (n=6637, 40% women). Linear and Poisson regression analyses were used to examine sex differences in cardiometabolic risk factor levels, treatment, and control.Results Compared with men, w... Mehr ...

Verfasser: Femke Rutters
Cees J Tack
Harold W de Valk
J Hans deVries
Miranda T Schram
Coen D A Stehouwer
Bruce H R Wolffenbuttel
Evertine J Abbink
Behiye Özcan
Petra J M Elders
Marieke J Oskam
Sarah E Siegelaar
Marielle Schroijen
Ingrid Jazet
L‘t Hart
N C Schaper
O M Dekkers
B Ozcan
B Silvius
M M van der Klauw
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Reihe/Periodikum: BMJ Open Diabetes Research & Care, Vol 8, Iss 1 (2020)
Verlag/Hrsg.: BMJ Publishing Group
Schlagwörter: Diseases of the endocrine glands. Clinical endocrinology / RC648-665
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26627817
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1136/bmjdrc-2020-001365